Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Prostate cancer+13

Recruiting

InvestigationalNo placebo

Study of JK06 for Patients with Advanced or Metastatic Cancer

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Jk06

Contact Research Centre

Prostate cancer+1

Recruiting

Registered drugNo placebo

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Docetaxel

Contact Research Centre

Prostate cancer+5

Recruiting

Registered drugNo placebo

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Comparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Bicalutamide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years
Substances:Gadoteric Acid

Contact Research Centre

Prostate cancer

Recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of 64Cu-DOTA-AE105 PET Imaging for Patients with Localized, Untreated Prostate Cancer

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:64Cu-Dota-Ae105

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Bicalutamide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of High-Dose Radiation Therapy Combined with Goserelin for High-Risk Prostate Cancer Patients Using AI-Based Treatment Planning

Registered drugNo placebo

Cyprus

Participants:18–64 years · 65+ years
Substances:Goserelin

Contact Research Centre

Prostate cancer+12

Recruiting

Registered drugNo placebo

Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Temozolomide

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Prostate Cancer After Radiation and Hormone Therapy

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Lutetium (177Lu) Vipivotide Tetraxetan

Contact Research Centre

Prostate cancer

Recruiting

Registered drug

Study on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Find therapies in clinical trials near you – page 2

101 trials match your criteria

Prostate cancer+13

Study of JK06 for Patients with Advanced or Metastatic Cancer

Prostate cancer+1

Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

Prostate cancer+5

Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Prostate cancer

Comparison of Short vs Long-term Hormone Therapy with Goserelin, Leuprorelin, or Triptorelin Combined with Radiation for Prostate Cancer Patients After Surgery

Prostate cancer

Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

Prostate cancer

Study on the Safety and Effectiveness of 64Cu-DOTA-AE105 PET Imaging for Patients with Localized, Untreated Prostate Cancer

Prostate cancer

Study on Bicalutamide and Drug Combination for Patients with Unfavorable Intermediate/High-Risk Prostate Cancer

Prostate cancer

Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

Prostate cancer

Study of High-Dose Radiation Therapy Combined with Goserelin for High-Risk Prostate Cancer Patients Using AI-Based Treatment Planning

Prostate cancer+12

Study of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers

Prostate cancer

Study of Lutetium (177Lu) Vipivotide Tetraxetan for Patients with High-Risk Prostate Cancer After Radiation and Hormone Therapy

Prostate cancer

Study on High-Risk Prostate Cancer Treatment Using Darolutamide, Relugolix, and Drug Combination for Eligible Patients

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.